Mirion Technologies Inc (MIR)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Mirion Technologies Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 7 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 15.00 $ — 3% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 8.8% failed
- More than 10% revenue growth is expected for the coming year 7.6% failed
- Share count grows by less than 3% a year 13.0% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 19.1% failed
- Gross margin at 40% or higher and without meaningful erosion 47.4% passed
- Goodwill from acquisitions does not grow faster than revenue 52.2% failed
- Net debt below twice EBITDA 3.8 x EBITDA failed
- Operating cash flow covers the profits of the last three years 442 m passed
- Return on capital at 15% or higher, or up versus two years ago 1.6% passed
- Insiders hold at least 10% or are net buyers 3.4% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 65.3% above the current price.
- Consensus
- Strong Sell
- Analyst Ratings
- 5
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 0.54 | 0.52 – 0.55 | 1,138 | 17.4% | 8 |
| 12/31/2027 | 0.66 | 0.61 – 0.71 | 1,224 | 22.2% | 7 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.07 | – | 254 | 10.40 | 5.90 | 61 | 49 |
| 2025: Q1 | 0.00 | – | 202 | 4.90 | 0.10 | 36 | 27 |
| 2025: Q2 | 0.03 | – | 223 | 7.60 | 3.70 | 10 | 1 |
| 2025: Q3 | 0.01 | – | 223 | 7.90 | 1.30 | 22 | 13 |
| 2025: Q4 | 0.07 | -9.50 | 277 | 9.10 | 6.20 | 76 | 66 |
| 2026: Q1 | -0.01 | -1,151.10 | 258 | 27.50 | -1.30 | 19 | 9 |
| 2026: Q2 | 0.03 | 0.00 | 267 | 19.70 | 2.90 | 59 | 48 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2009 | – | – | – | – | 8 | – | – |
| 2017 | 444 | 0 | 0 | 0.00 | 16 | – | – |
| 2018 | 444 | -5 | -104 | -1.09 | 16 | 0 | 0 |
| 2019 | 478 | 0 | 0 | 0.00 | 15 | 0 | 0 |
| 2020 | 478 | -2 | -45 | -0.79 | 40 | 724 | 751 |
| 2021 | 612 | 11 | -158 | -0.76 | 1 | 1,693 | 3,118 |
| 2022 | 718 | -298 | -277 | -1.53 | 39 | 1,398 | 2,739 |
| 2023 | 801 | -22 | -97 | -0.49 | 95 | 1,485 | 2,719 |
| 2024 | 861 | 25 | -36 | -0.18 | 99 | 1,506 | 2,636 |
| 2025 | 925 | 52 | 29 | 0.11 | 143 | 1,866 | 3,588 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Mirion Technologies, Inc. bietet Produkte und Dienstleistungen für Strahlungserkennung, -messung, -analyse und -überwachung in Nordamerika, Europa und im asiatisch-pazifischen Raum an.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 3,200 |
| Headquarters | Atlanta, GA |
| Address | 1218 Menlo Drive, 30318 Atlanta, United States |
| Phone | 770 432 2744 |
| Website | mirion.com |
| IPO Date | 20. Aug 2020 |
| ISIN | US60471A1016 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Thomas D. Logan | Founder, Medical Group President, CEO & Chairman | 1961 |
| Brian Schopfer | CFO & Medical Group President | 1985 |
| Emmanuelle Lee J.D. | Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary | – |
| Alison Ulrich | Chief Human Resources Officer | – |
| Loic Eloy | Group President of Nuclear & Safety Technologies | 1977 |
| Christopher Moore CPA | Chief Accounting Officer | 1972 |
| James Francis Charles Cocks | Chief Technology Officer | – |
| Marc Rubel | Chief Information Officer | – |
| Eric Linn | Vice President of Investor Relations | – |
| Erin Schesny | CMO & Senior VP of Government Affairs | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.